Impact of innovation in oncology: more questions than answers

Gianpiero Fasola1,2, Maria Carla Barducci3, Giordano Beretta4,5

  • 1Oncology Department, University Hospital S. Maria della Misericordia, Udine, Italy.

Tumori
|June 28, 2021
PubMed

Insights

Oncology innovations are improving cancer survival rates and reducing deaths. However, these advancements increase healthcare complexity, requiring system-level adaptations for professionals and patients.

Area of Science:

  • Oncology
  • Medical Innovation
  • Healthcare Systems

Background:

  • Oncology is experiencing unprecedented innovation, leading to improved patient survival and reduced cancer mortality since 1991.
  • New cancer drug approvals and advancements in diagnostics and treatment have significantly decreased death rates for common cancers.
  • Increasing cancer prevalence is observed across Western countries, highlighting a growing patient population.

Discussion:

  • The rapid pace of innovation in oncology generates a vast volume of new knowledge.
  • The expanding prevalence of cancer survivors presents unique clinical, social, and organizational challenges.
  • Healthcare systems face increased complexity due to these concurrent trends in oncology.

Key Insights:

  • Medical innovations in oncology have demonstrably reduced cancer-related deaths.
  • The growing number of cancer survivors necessitates a re-evaluation of healthcare delivery models.
  • Increased complexity in oncology care impacts healthcare professionals and system efficiency.

Outlook:

  • Healthcare systems must adapt to manage the growing volume of oncological knowledge and patient prevalence.
  • Strategies are needed to address the clinical, social, and organizational complexities arising from oncology advancements.
  • Proactive adjustments in healthcare systems are crucial to sustain and optimize the benefits of cancer innovation.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
785
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
588